vs
DOMO, INC.（DOMO）与MEDIFAST INC（MED）财务数据对比。点击上方公司名可切换其他公司
DOMO, INC.的季度营收约是MEDIFAST INC的1.1倍（$79.4M vs $75.1M），DOMO, INC.同比增速更快（-0.5% vs -36.9%），DOMO, INC.自由现金流更多（$1.1M vs $-6.6M），过去两年DOMO, INC.的营收复合增速更高（-0.5% vs -34.4%）
Domo股份有限公司是总部设在美国犹他州美国福克的美国云软件企业，主营人工智能、商业智能与数据可视化业务，属于SaaS（软件即服务）企业，核心产品可帮助企业各层级决策者在极少IT介入的情况下，实时获取业务数据，支撑决策开展。
迈德福斯特是一家总部位于美国马里兰州巴尔的摩的营养减重企业，该公司研发、分销并销售减重及健康相关产品，销售渠道涵盖官方网站、多层次营销、电话销售以及品牌加盟减重诊所。
DOMO vs MED — 直观对比
营收规模更大
DOMO
是对方的1.1倍
$75.1M
营收增速更快
DOMO
高出36.4%
-36.9%
自由现金流更多
DOMO
多$7.7M
$-6.6M
两年增速更快
DOMO
近两年复合增速
-34.4%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $79.4M | $75.1M |
| 净利润 | $-10.4M | — |
| 毛利率 | 74.2% | 69.4% |
| 营业利润率 | -8.7% | -10.4% |
| 净利率 | -13.1% | — |
| 营收同比 | -0.5% | -36.9% |
| 净利润同比 | 44.6% | — |
| 每股收益（稀释后） | $-0.25 | $-1.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMOMED
| Q4 25 | $79.4M | $75.1M | ||
| Q3 25 | $79.7M | $89.4M | ||
| Q2 25 | $80.1M | $105.6M | ||
| Q1 25 | $78.8M | $115.7M | ||
| Q4 24 | $79.8M | $119.0M | ||
| Q3 24 | $78.4M | $140.2M | ||
| Q2 24 | $80.1M | $168.6M | ||
| Q1 24 | $80.2M | $174.7M |
净利润DOMOMED
| Q4 25 | $-10.4M | — | ||
| Q3 25 | $-22.9M | $-2.3M | ||
| Q2 25 | $-18.1M | $2.5M | ||
| Q1 25 | $-17.7M | $-772.0K | ||
| Q4 24 | $-18.8M | — | ||
| Q3 24 | $-19.5M | $1.1M | ||
| Q2 24 | $-26.0M | $-8.2M | ||
| Q1 24 | $-18.7M | $8.3M |
毛利率DOMOMED
| Q4 25 | 74.2% | 69.4% | ||
| Q3 25 | 74.8% | 69.5% | ||
| Q2 25 | 74.2% | 72.6% | ||
| Q1 25 | 74.4% | 72.8% | ||
| Q4 24 | 75.0% | 74.1% | ||
| Q3 24 | 74.3% | 75.4% | ||
| Q2 24 | 74.1% | 73.2% | ||
| Q1 24 | 76.3% | 72.8% |
营业利润率DOMOMED
| Q4 25 | -8.7% | -10.4% | ||
| Q3 25 | -9.1% | -4.6% | ||
| Q2 25 | -17.9% | -1.0% | ||
| Q1 25 | -15.6% | -1.1% | ||
| Q4 24 | -13.9% | 0.6% | ||
| Q3 24 | -18.5% | 1.5% | ||
| Q2 24 | -26.8% | -4.7% | ||
| Q1 24 | -16.6% | 4.5% |
净利率DOMOMED
| Q4 25 | -13.1% | — | ||
| Q3 25 | -28.8% | -2.5% | ||
| Q2 25 | -22.5% | 2.3% | ||
| Q1 25 | -22.4% | -0.7% | ||
| Q4 24 | -23.5% | — | ||
| Q3 24 | -24.9% | 0.8% | ||
| Q2 24 | -32.5% | -4.8% | ||
| Q1 24 | -23.3% | 4.8% |
每股收益（稀释后）DOMOMED
| Q4 25 | $-0.25 | $-1.64 | ||
| Q3 25 | $-0.56 | $-0.21 | ||
| Q2 25 | $-0.45 | $0.22 | ||
| Q1 25 | $-0.45 | $-0.07 | ||
| Q4 24 | $-0.48 | $0.08 | ||
| Q3 24 | $-0.51 | $0.10 | ||
| Q2 24 | $-0.69 | $-0.75 | ||
| Q1 24 | $-0.51 | $0.76 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $167.3M |
| 总债务越低越好 | $124.2M | — |
| 股东权益账面价值 | $-191.9M | $198.9M |
| 总资产 | $201.6M | $248.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOMOMED
| Q4 25 | — | $167.3M | ||
| Q3 25 | — | $173.5M | ||
| Q2 25 | $47.2M | $162.7M | ||
| Q1 25 | $45.3M | $164.6M | ||
| Q4 24 | — | $162.3M | ||
| Q3 24 | — | $170.0M | ||
| Q2 24 | $61.2M | $163.5M | ||
| Q1 24 | $60.9M | $156.4M |
总债务DOMOMED
| Q4 25 | $124.2M | — | ||
| Q3 25 | $121.9M | — | ||
| Q2 25 | $119.7M | — | ||
| Q1 25 | $117.7M | — | ||
| Q4 24 | $115.6M | — | ||
| Q3 24 | $115.2M | — | ||
| Q2 24 | $114.1M | — | ||
| Q1 24 | $113.5M | — |
股东权益DOMOMED
| Q4 25 | $-191.9M | $198.9M | ||
| Q3 25 | $-191.5M | $214.7M | ||
| Q2 25 | $-178.7M | $216.0M | ||
| Q1 25 | $-177.2M | $211.0M | ||
| Q4 24 | $-171.2M | $210.1M | ||
| Q3 24 | $-166.4M | $207.3M | ||
| Q2 24 | $-163.5M | $205.3M | ||
| Q1 24 | $-153.5M | $211.0M |
总资产DOMOMED
| Q4 25 | $201.6M | $248.0M | ||
| Q3 25 | $195.7M | $268.2M | ||
| Q2 25 | $189.7M | $269.3M | ||
| Q1 25 | $214.3M | $280.0M | ||
| Q4 24 | $190.2M | $284.2M | ||
| Q3 24 | $197.8M | $291.2M | ||
| Q2 24 | $204.4M | $293.5M | ||
| Q1 24 | $225.7M | $302.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.4M | $-5.3M |
| 自由现金流经营现金流 - 资本支出 | $1.1M | $-6.6M |
| 自由现金流率自由现金流/营收 | 1.4% | -8.8% |
| 资本支出强度资本支出/营收 | 2.9% | 1.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $9.9M | $1.2M |
8季度趋势，按日历期对齐
经营现金流DOMOMED
| Q4 25 | $3.4M | $-5.3M | ||
| Q3 25 | $3.4M | $12.1M | ||
| Q2 25 | $4.0M | $-3.4M | ||
| Q1 25 | $8.9M | $3.4M | ||
| Q4 24 | $-13.7M | $-4.9M | ||
| Q3 24 | $-6.2M | $9.1M | ||
| Q2 24 | $1.9M | $13.1M | ||
| Q1 24 | $5.4M | $7.3M |
自由现金流DOMOMED
| Q4 25 | $1.1M | $-6.6M | ||
| Q3 25 | $1.0M | $10.8M | ||
| Q2 25 | $1.0M | $-4.8M | ||
| Q1 25 | $6.7M | $1.9M | ||
| Q4 24 | $-16.2M | $-7.2M | ||
| Q3 24 | $-8.4M | $7.7M | ||
| Q2 24 | $-625.0K | $11.1M | ||
| Q1 24 | $2.9M | $5.4M |
自由现金流率DOMOMED
| Q4 25 | 1.4% | -8.8% | ||
| Q3 25 | 1.3% | 12.0% | ||
| Q2 25 | 1.3% | -4.5% | ||
| Q1 25 | 8.5% | 1.6% | ||
| Q4 24 | -20.3% | -6.1% | ||
| Q3 24 | -10.7% | 5.5% | ||
| Q2 24 | -0.8% | 6.6% | ||
| Q1 24 | 3.6% | 3.1% |
资本支出强度DOMOMED
| Q4 25 | 2.9% | 1.8% | ||
| Q3 25 | 2.9% | 1.5% | ||
| Q2 25 | 3.7% | 1.3% | ||
| Q1 25 | 2.8% | 1.3% | ||
| Q4 24 | 3.2% | 1.9% | ||
| Q3 24 | 2.8% | 1.0% | ||
| Q2 24 | 3.2% | 1.1% | ||
| Q1 24 | 3.1% | 1.1% |
现金转化率DOMOMED
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.36× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 8.04× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
MED
暂无分部数据
